BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$2.68 -0.04 (-1.47%)
At close: Oct 21, 2026 · 4:00 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Change in Other Operating Liabilities (2024 - 2026)

Updated

Analysis

BridgeBio Oncology Therapeutics (BBOT) Change in Other Operating Liabilities (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -972.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -112.00 Mn
10 BridgeBio Oncology Therapeutics 213.74 Mn -1.16 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 757,000.00
Dec 31, 2025 -3.81 Mn
Sep 30, 2025 3.33 Mn
Mar 31, 2025 944,000.00
Dec 31, 2024 917,000.00
API Access

BridgeBio Oncology Therapeutics Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=BBOT&period=max&api_key=YOUR_API_KEY